Veit Metzler

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Florent G. Revel, Jean‐Luc Moreau, Raul R. Gainetdinov et al. · Proceedings of the National Academy of Sciences · 2011 · 365 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

F. Revel, J‐L Moreau, Bruno Pouzet et al. · Molecular Psychiatry · 2012 · 286 citations

Medicine, Neuroscience, Pharmacology +16

Characterization of [³H]‐(2S,2′R,3′R)‐2‐(2′,3′‐dicarboxy‐ cyclopropyl)glycine ([³H]‐DCG IV) binding to metabotropic mGlu₂ receptor‐transfected cell membranes

Jayne Cartmell, Geo Adam, Sylvie Chaboz et al. · British Journal of Pharmacology · 1998 · 83 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Characterization of [³H]Quisqualate Binding to Recombinant Rat Metabotropic Glutamate 1a and 5a Receptors and to Rat and Human Brain Sections

Vincent Mutel, Gareth J. Ellis, Geo Adam et al. · Journal of Neurochemistry · 2000 · 62 citations · Full text

Life Sciences, Neuroscience, Pharmacology +13